| Rilpivirine | 🇺🇸United States | 2.5MG | tablet | Tentative approval | Somerset Theraps LLC |
| Rilpivirine | 🇺🇸United States | 25MG | tablet | Tentative approval | Strides Arcolab LTD |
| Rilpivirine Hydrochloride | 🇺🇸United States | 25MG BASE | tablet | Marketed | Somerset Theraps LLC |
| Emtricitabine, Rilpivirine and Tenofovir Disoproxil FumarateCombination | 🇺🇸United States | 200MG; 25MG BASE; 300MG | tablet | Marketed | Laurus |
| Emtricitabine / Rilpivirine / Tenofovir Alafenamide ViatrisCombination | 🇪🇺European Union | | | Authorised | Viatris Limited |
| Emtricitabine, Rilpivirine, and Tenofovir AlafenamideCombination | 🇺🇸United States | 200MG; 25MG BASE; 25MG BASE | tablet | Marketed | Apotex |
| Emtricitabine/rilpivirine/tenofoviralafenamide Viatris 200 mg/25 mg/25 mg filmomhulde tabletten.Combination | 🇳🇱Netherlands | | Filmomhulde tablet | Authorised | Viatris Limited |
| Edurant | 🇺🇸United States | 25MG BASE | tablet | Marketed | Janssen Prods |
| Edurant Ped | 🇺🇸United States | 2.5MG BASE | tablet, for suspension | Marketed | Janssen Prods |
| CabenuvaCombination | 🇨🇦Canada | 200 MG / ML + 300 MG / ML | Kit, Suspension (Extended-Release) | Marketed | Viiv Healthcare Ulc |
| CabenuvaCombination | 🇨🇦Canada | 200 MG / ML + 300 MG / ML | Kit, Suspension (Extended-Release) | Marketed | Viiv Healthcare Ulc |
| Dolutegravir; RilpivirineCombination | 🇺🇸United States | 50MG/25MG | tablet | Tentative approval | Lupin LTD |
| Emtricitabine; Rilpivirine; Tenofovir AlafenamideCombination | 🇺🇸United States | 200MG; 25MG; 25MG | tablet | Tentative approval | Cipla Limited |
| Emtricitabina/Rilpivirina/Tenofovir Alafenamide ViatrisCombination | 🇮🇹Italy | | Compressa rivestita con film | Authorised | Viatris Limited |
| Emtricitabina/Rilpivirina/Tenofovir Alafenamida Viatris 200 MG/25 MG/25 MG Comprimidos Recubiertos con Pelicula EfgCombination | 🇪🇸Spain | 200 mg + 25 mg + 25 mg | comprimido recubierto con película | Authorised | Viatris Limited |
| Cabenuva KitCombination | 🇺🇸United States | 400MG/2ML (200MG/ML); 600MG/2ML, 600MG/3ML (200MG/ML); 900MG/3ML | suspension, extended release | Marketed | Viiv Hlthcare |
| JulucaCombination | 🇺🇸United States | 50MG BASE; 25MG BASE | tablet | Marketed | Viiv Hlthcare |
| Rekambys | 🇪🇺European Union | | | Authorised | Janssen-Cilag International NV |
| EDURANT 25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | 🇪🇸Spain | 25 mg | comprimido recubierto con película | Marketed | Janssen-Cilag International N.V |
| Juluca 50 MG/25 MG Comprimidos Recubiertos con PeliculaCombination | 🇪🇸Spain | 52,62 mg + 27,50 mg | comprimido recubierto con película | Marketed | Viiv Healthcare B.V. |
| Odefsey 200 MG/25 MG/25 MG Comprimidos Recubiertos con PeliculaCombination | 🇪🇸Spain | 200 mg + 25 mg + 25 mg | comprimido recubierto con película | Marketed | Gilead Sciences Ireland Unlimited Company |
| EVIPLERA 200 mg/25 mg/245 mg COMPRIMIDOS RECUBIERTOS CON PELICULACombination | 🇪🇸Spain | 200 mg + 27,5 mg + 300 mg | comprimido recubierto con película | Marketed | Gilead Sciences Ireland Unlimited Company |
| Rekambys 900 MG Suspension Inyectable de Liberacion Prolongada | 🇪🇸Spain | 300 mg/ml | suspension inyectable de liberacion prolongada | Marketed | Janssen-Cilag International N.V |
| Edurant | 🇪🇺European Union | | | Authorised | Janssen-Cilag International N.V. |
| EvipleraCombination | 🇪🇺European Union | | | Authorised | Gilead Sciences International Ltd |
